Newest tools and technologies on the PAD-treatment horizon

In this PVI 2024 session dedicated to the treatment of peripheral arterial disease (PAD), explore the latest tools and emerging technologies shaping the field. 

The session highlights the results of a survey on the management of de novo and restenotic lesions in the SFA and popliteal arteries, providing valuable insights into current clinical practice. 

Attention is given to bioresorbable drug-eluting scaffolds, a highly anticipated technology that shows promise but will require longer scaffolds and further studies, including direct comparisons with metallic DES. 

Advances in perfusion assessment for CLTI are also discussed, with hyperpectral imaging emerging as a potential new option.

 The role of percutaneous transmural arterial bypass as an easy-to-use alternative for complex femoropopliteal lesions is reviewed, demonstrating encouraging early results while leaving some questions open for future research. 

Finally, the session offers guidance on imaging devices—including angiography, IVUS, EVUS, and CO₂ angiography—helping clinicians identify which tools are most likely to improve patient outcomes and justify extra time or cost. 

Overall, this session provides a comprehensive overview of both current strategies and future directions in PAD treatment, giving physicians practical insights to enhance their clinical decision-making.